Twenty-six students with businesses ranging from drinking water treatment to alternative medicine to kitchen robots, received fellowships to work on their businesses this summer.
Four Cornell faculty members from three different colleges received the 2022 Kappa Delta Ann Doner Vaughn Award for their collaborative research on the mechanics and composition of articular cartilage and its relevance to disease.
Professor of economics Jörg Stoye proposes new methods of deriving the prevalence of a disease when only partial data is available — with applications for epidemiology and public health policy.
This year’s Lund Critical Debate, “Migration in the Age of Pandemics,” on February 16 will explore ways to promote the best public health outcomes worldwide and protect human rights, as waves of people cross national borders.
An FDA-approved drug that has been in clinical use for more than 70 years may protect against lung injury in severe COVID-19 cases, according to a preclinical study from researchers at Weill Cornell Medicine and Cold Spring Harbor Laboratory.
The eighth episode of a podcast hosted by Entrepreneurship at Cornell, Startup Cornell, features Rich Horgan ‘14, founder of Cure Rare Disease, a non-profit biotech company.
Many in the workforce have turned to Nellie Brown, director of Workplace Health and Safety Programs at the ILR School, for guidance on how to keep their workplaces safe from COVID-19
Scientists at Weill Cornell Medicine have developed a pipeline that will enable study of the biological roles of gut bacteria, recognized as key factors in health and disease.
A growth factor protein produced by rare immune cells in the intestine can protect against the effects of inflammatory bowel disease, according to a new discovery from Weill Cornell Medicine researchers.
